Effects of Repetitive Transcranial Magnetic Stimulation on Two Cerebellar Targets

NCT07561229 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-01

No results posted yet for this study

Summary

The purpose of this study is to understand how different areas of the cerebellum (a part of the brain) control different functions and how they can be influenced by non-invasive brain stimulation.

While researchers know that repetitive Transcranial Magnetic Stimulation (rTMS) can have positive effects on conditions like stroke and schizophrenia, they do not yet fully understand which specific stimulation settings work best or which exact parts of the cerebellum should be targeted for different symptoms.

This study compares the effects of stimulation on two specific regions:

* Lobule VIII: Linked to movement and motor learning.
* CRUS I/II: Linked to attention, thinking (cognition), and predicting the timing of events.By comparing these areas, researchers hope to gain the information needed to develop better treatments for neurological and psychiatric disorders.

This is a randomized, double-blind study involving 40 healthy volunteers. Participants will be split into two groups:

* Group 1: Receives "exciting" (activity-increasing) stimulation.
* Group 2: Receives "inhibiting" (activity-decreasing) stimulation.

Each participant will attend three different test sessions in a random order:

* rTMS targeting Lobule VIII
* rTMS targeting CRUS I/II
* Placebo (Sham) stimulation that looks and feels like the real thing but does not affect the brain.

During each session, researchers will use brain imaging (fMRI) and computerized tasks to measure changes in brain connectivity and performance in motor and cognitive activities.

There is no direct medical benefit to the participants. However, the results will help scientists create better therapies for patients with brain-related health issues The risks are considered minimal. Common side effects of rTMS include temporary mild headaches or a clicking sound during stimulation. MRI scans can sometimes cause mild discomfort or a feeling of closed-in spaces (claustrophobia). Researchers have put safety measures in place, such as hearing protection and constant medical supervision during scans, to minimize these risks.

Conditions

  • Healthy
  • Healthy Adult

Interventions

DEVICE

Sham rTMS

The coil looks and sounds identical to the active coil and is placed in the same positions (counterbalanced between Lobule VIII and Crus I/II sites). It provides the physical sensation and auditory "click" of TMS without delivering a significant magnetic field to the brain tissue, maintaining the study's double-blind integrity.

BEHAVIORAL

Cognitive and Motor Assessment Battery

Participants perform three computerized tasks to evaluate the functional impact of the rTMS: * Visuomotor Task: A joystick-based task assessing motor coordination and learning (linked to Lobule VIII). * Temporal Prediction Task: A visual task requiring the participant to predict the timing of an event (linked to Crus I/II). * Mental Imagery \& Finger Tapping: A task assessing the cognitive representation of movement.

DEVICE

Active rTMS - Lobule VIII

Either excitatory (e.g., iTBS) or inhibitory (e.g., cTBS) depending on the assigned group.

DEVICE

Active rTMS - Crus I/II

Participants receive rTMS targeting the Crus I/II of the cerebellum. Either excitatory (e.g., iTBS) or inhibitory (e.g., cTBS) depending on the assigned group.

Sponsors & Collaborators

  • ICube Laboratory

    collaborator UNKNOWN
  • University Hospital, Strasbourg, France

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2030-01-02
Completion
2030-01-02

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07561229 on ClinicalTrials.gov